Product Reports Resources Pricing Login Book a demo

Athelas

Biotech & Life Sciences · Mountain View, United States · Founded 2016

Provides healthcare products and medical billing services

Valuation $1–2.5B
Revenue $100–500M
Headcount 100–500
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Athelas and the history behind them.
Power Law Unicorn$1–10B valuation tier Thoroughbred$100M+ revenue

Talent graph

Athelas's talent

Book a demo to see the people
Employees mapped 336 incl. 5 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 10 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia 7 alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

16 investors on Athelas's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Seed 8 investors entered at this stage
Sequoia
Fifty Years
Initialized Capital
Shasta Ventures
Y Combinator
Dorm Room Fund
Liquid 2 Ventures
CSC Upshot
Series A 3 investors entered at this stage
Aravis Ventures
VI Partners
Novartis Venture Fund
Series B+ 5 investors entered at this stage
General Catalyst
Human Capital
Tribe Capital
Greenoaks Capital Partners
Fidelity Investments

Athelas mafia

Startups founded by Athelas alumni

Former Athelas employees who went on to start their own companies. Sorted by Dealroom signal score.

Assort HealthEst. 2023
Jeffery L.United States
Signal score96
CommureEst. 2017
Tanay TandonUnited States
Signal score95
DossEst. 2022
Wiley JonesUnited States
Signal score93
FoundationEst. 2024
Arjun SethiUnited States
Signal score91
Blossom HealthEst. 2024
JZJohn ZhaoUnited States
Signal score88
SellScaleEst. 2022
Ishan SharmaUnited States
Signal score81
Dots ��Est. 2021
Kartikye MittalUnited States
Signal score79

Book a demo to explore the full alumni network →

Global footprint

Where Athelas has talent and traffic

Workforce by country
11 countries with
team presence
🇺🇸 United States89.4%
🇮🇳 India7%
🇧🇷 Brazil1.4%
🇧🇩 Bangladesh0.3%
🇪🇸 Spain0.3%
Top 5 of 11 shown
Web traffic by country
340K monthly visits
across markets
🇺🇸 United States97.9%
🇬🇧 United Kingdom0.7%
🇮🇳 India0.6%
🇨🇦 Canada0.4%
🇮🇩 Indonesia0.4%
Top 5 markets shown

Patent intelligence

$274k patent portfolio · 3 active families

Estimated portfolio value
$274k
0.02% of valuation · 85.5× smaller than top peer Recursion Pharma ($23M)
3 active patent families
Where Athelas innovates Cell typeCell type specificCell typingChemistryDisplay device

Where Athelas concentrates vs peers

Each axis is a top-10 topic across Athelas and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Athelas

An AI-synthesized read of the highest-engagement posts about Athelas on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Athelas on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles